Worldwide osteoarthritis (OA) affects more than 9.6% of men and 18% of women older that 60 years. Treatment for OA often requires chronic use of selective or nonselective nonsteroidal antiinflammatory drugs (NSAIDs), which have been associated with gastrointestinal and cardiovascular complications.
